Literature DB >> 7495507

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

S L Rowland-Jones1, A McMichael.   

Abstract

Over the past two years, a number of reports have described specific cellular immune responses to HIV in some individuals who, despite exposure to the virus, remain uninfected. A recent description of virus disappearance in a child born to an infected mother should be seen against the background of several previous studies that have hinted at the possibility of clearance of HIV. These findings suggest that immune-mediated clearance of virus may occur in a few fortunate individuals.

Entities:  

Mesh:

Year:  1995        PMID: 7495507     DOI: 10.1016/0952-7915(95)80087-5

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  32 in total

Review 1.  The search for an HIV vaccine.

Authors:  Malegapuru William Makgoba; Nandipha Solomon; Timothy Johan Paul Tucker
Journal:  BMJ       Date:  2002-01-26

2.  Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.

Authors:  R Kaul; S L Rowland-Jones; J Kimani; T Dong; H B Yang; P Kiama; T Rostron; E Njagi; J J Bwayo; K S MacDonald; A J McMichael; F A Plummer
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 3.  Resistance to HIV infection.

Authors:  M Marmor; K Hertzmark; S M Thomas; P N Halkitis; M Vogler
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

4.  Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection.

Authors:  M A Nowak; A L Lloyd; G M Vasquez; T A Wiltrout; L M Wahl; N Bischofberger; J Williams; A Kinter; A S Fauci; V M Hirsch; J D Lifson
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.

Authors:  Silvana Tasca; Lily Tsai; Nataliya Trunova; Agegnehu Gettie; Mohammed Saifuddin; Rudolf Bohm; Lisa Chakrabarti; Cecilia Cheng-Mayer
Journal:  Virology       Date:  2007-06-15       Impact factor: 3.616

Review 6.  HIV: is a vaccine the answer?

Authors:  Sumit Chawla; Soumya Swaroop Sahoo; Rambilas Jain; Pardeep Khanna; Bharti Mehta; Inderjeet Singh
Journal:  Hum Vaccin Immunother       Date:  2013-09-04       Impact factor: 3.452

7.  Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment.

Authors:  C C Tsai; P Emau; K E Follis; T W Beck; R E Benveniste; N Bischofberger; J D Lifson; W R Morton
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

8.  C-C chemokines, pivotal in protection against HIV type 1 infection.

Authors:  D Zagury; A Lachgar; V Chams; L S Fall; J Bernard; J F Zagury; B Bizzini; A Gringeri; E Santagostino; J Rappaport; M Feldman; S J O'Brien; A Burny; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

9.  A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.

Authors:  Kenji Someya; Ke-Qin Xin; Kazuhiro Matsuo; Kenji Okuda; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Human immunodeficiency virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India.

Authors:  Suresh Pallikkuth; Ajay Wanchu; Archana Bhatnagar; Ravinder Kaur Sachdeva; Meera Sharma
Journal:  Clin Vaccine Immunol       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.